title: Effect of lipopolysaccharide on P-glycoprotein-mediated intestinal and biliary excretion of rhodamine123 in rats.
abstract: The effects of lipopolysaccharide (LPS) on the ileal and biliary excretion of rhodamine123 were investigated in rats at different times after intraperitoneal (i.p.) injection (1 mg/kg and 5 mg/kg of body weight). P-gp protein decreased 8h after injection of LPS and returned to the control level 24h after i.p. injection of LPS in the ileum. There was a marked decrease in the expression level of mdr1a mRNA in the ileum and liver 8h after i.p. injection of LPS when compared with the control condition. Also, the ileal and biliary clearance of rhodamine123 significantly decreased 8h after i.p. injection of LPS, but returned to the control levels 24h after i.p. injection of LPS. These results suggest that LPS-induced decreases in P-gp-mediated ileal and biliary excretion of rhodamine123 were probably due to impaired P-gp-mediated transport ability. The levels of iNOS and IL-1beta mRNA in the ileum and liver increased 2 and 8h after i.p. injection of LPS, respectively, and returned to the control levels 24h after injection of LPS. These findings suggest that LPS markedly decreases P-gp-mediated ileal and biliary excretion of rhodamine123, probably by partly decreasing the expression of P-gp protein levels, likely due to increased lipid peroxidation levels through iNOS mRNA and inflammatory mediators such as IL-1beta.
authors.affiliation: Department of Drug Absorption and Pharmacokinetics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. tomita@toyaku.ac.jp
authors.forename: Mikio
authors.initials: M
authors.lastname: Tomita
authors.forename: Atsushi
authors.initials: A
authors.lastname: Kanbayashi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Murata
authors.forename: Ayako
authors.initials: A
authors.lastname: Tanaka
authors.forename: Mariko
authors.initials: M
authors.lastname: Nakaike
authors.forename: Megumi
authors.initials: M
authors.lastname: Hatanaka
authors.forename: Masahiro
authors.initials: M
authors.lastname: Hayashi
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B / Q000235:genetics*; D000818:Animals; D001646:Bile / Q000737:chemistry; D015153:Blotting, Western; D015870:Gene Expression / Q000187:drug effects; D007082:Ileum / Q000187:drug effects* / Q000378:metabolism; D008658:Inactivation, Metabolic; D008070:Lipopolysaccharides / Q000633:toxicity*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D020133:Reverse Transcriptase Polymerase Chain Reaction; D020112:Rhodamine 123 / Q000097:blood / Q000493:pharmacokinetics*; D000097202:ATP-Binding Cassette Sub-Family B Member 4
chemical_list: D018435:ATP Binding Cassette Transporter, Subfamily B; D008070:Lipopolysaccharides; D020112:Rhodamine 123; D000097202:ATP-Binding Cassette Sub-Family B Member 4; C440499:lipopolysaccharide, Escherichia coli O111 B4; C095122:multidrug resistance protein 3